RIVAROXABAN

Clinical Indication

Treatment and secondary prevention of DVT and PE

Comments

In line with  NICE TA 261  or  NICE TA 287

Date of classification

September 2012

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .